Asmaa Quessar Selected Research

Asmaa Quessar Research Topics

5	Neoplasms (Cancer) 11/2022 - 04/2015
3	Leukemia 06/2022 - 03/2012
3	Infections 04/2015 - 06/2013
2	Hematologic Neoplasms (Hematological Malignancy) 11/2022 - 01/2019
2	Cytokine Release Syndrome 01/2020 - 01/2019
2	Lymphoma (Lymphomas) 12/2018 - 01/2017
1	Multiple Myeloma 01/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2020
1	Brain Diseases (Brain Disorder) 01/2020
1	Thymoma (Thymic Carcinoma) 12/2018
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2017
1	Hematologic Diseases (Blood Diseases) 04/2015
1	Factor VII Deficiency (Hypoproconvertinemia) 04/2015
1	Sepsis (Septicemia) 04/2015
1	Aplastic Anemia (Anemia, Hypoplastic) 04/2015
1	Neutropenia 06/2013
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2012
1	Acute Promyelocytic Leukemia 09/2011
1	Anemia 12/2007
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 12/2007
1	Pernicious Anemia 12/2007
1	Burkitt Lymphoma (Burkitt's Lymphoma) 02/2005

1	Biomarkers (Surrogate Marker)IBA 11/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2022
1	HLA-DR Antigens (HLA-DR)IBA 06/2022
1	Imatinib Mesylate (Gleevec)FDA Link 09/2020
1	Tyrosine Kinase InhibitorsIBA 09/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Etoposide (VP 16)FDA LinkGeneric 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	Chimeric Antigen ReceptorsIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2013
1	Core Binding Factors (Core-Binding Factor)IBA 03/2012
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2011
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 12/2007

5	Therapeutics 06/2022 - 12/2007
4	Drug Therapy (Chemotherapy) 01/2021 - 06/2013
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2020 - 04/2015
1	Cell Transplantation 12/2021
1	Hematopoietic Stem Cell Transplantation 01/2021
1	Stem Cell Transplantation 01/2021
1	Radiotherapy 01/2019
1	Aftercare (After-Treatment) 12/2018
1	Length of Stay 03/2014
1	LMB89 protocol 02/2005